The effect of renal denervation on kidney oxygenation as determined by BOLD MRI in patients with hypertension

ObjectivesRenal denervation (RDN) is a promising therapy for resistant hypertension. RDN is assumed to decrease sympathetic activity. Consequently, RDN can potentially increase renal oxygenation. Blood oxygen level-dependent MRI (BOLD-MRI) provides a non-invasive tool to determine renal oxygenation in humans. The aim of the current study was to investigate the effect of RDN on renal oxygenation as determined by BOLD-MRI.MethodsPatients with resistant hypertension or the inability to follow a stable drug regimen due to unacceptable side effects were included. BOLD-MRI was performed before and 12 months after RDN. Twenty-seven patients were imaged on 3 T and 19 on 1.5 T clinical MRI systems.ResultsFifty-four patients were included, 46 patients (23 men, mean age 57 years) completed the study. Mean 24-h BP changed from 163(±20)/98(±14) mmHg to 154(±22)/92(±13) mmHg (p = 0.001 and p < 0.001). eGFR did not change after RDN [77(±18) vs. 79(±20) mL/min/1.73 m2;p = 0.13]. RDN did not affect renal oxygenation [1.5 T: cortical R2*: 12.5(±0.9) vs. 12.5(±0.9), p = 0.94; medullary R2*: 19.6(±1.7) vs. 19.3(1.4), p = 0.40; 3 T: cortical R2*: 18.1(±0.8) vs. 17.8(±1.2), p = 0.47; medullary R2*: 27.4(±1.9) vs. 26.7(±1.8), p = 0.19].ConclusionThe current study shows that RDN does not lead to changes in renal oxygenation 1 year after RDN as determined by BOLD-MRI.Key Points• Renal denervation significantly decreased ambulatory blood pressure.• Renal denervation did not change renal oxygenation as determined by BOLD-MRI.• Absence of a change in renal oxygenation might be explained by autoregulation.

[1]  S. Umemura,et al.  Antihypertensive Effects and Pharmacokinetics of Single and Consecutive Administration of Doxazosin in Patients with Mild to Moderate Essential Hypertension , 1987, Journal of cardiovascular pharmacology.

[2]  M. Koss,et al.  A limited renal injury may cause a permanent form of neurogenic hypertension. , 1998, American journal of hypertension.

[3]  B. Waeber,et al.  Clinical value of ambulatory blood pressure monitoring in the assessment of antihypertensive therapy. , 1999, Blood pressure monitoring.

[4]  F. Epstein,et al.  Effects of furosemide on medullary oxygenation in younger and older subjects. , 2000, Kidney international.

[5]  W. Welch INTRARENAL OXYGEN AND HYPERTENSION , 2006, Clinical and experimental pharmacology & physiology.

[6]  Pottumarthi V. Prasad,et al.  Evaluation of Intra-Renal Oxygenation by BOLD MRI , 2006, Nephron Clinical Practice.

[7]  A. Dominiczak,et al.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.

[8]  Sean B Fain,et al.  BOLD-MRI assessment of intrarenal oxygenation and oxidative stress in patients with chronic kidney allograft dysfunction. , 2007, American journal of physiology. Renal physiology.

[9]  M. Khamaisi,et al.  Renal Parenchymal Hypoxia, Hypoxia Response and the Progression of Chronic Kidney Disease , 2008, American Journal of Nephrology.

[10]  P. Prasad,et al.  Blood oxygen level-dependent MR imaging of the kidneys. , 2008, Magnetic resonance imaging clinics of North America.

[11]  S. Riederer,et al.  The use of magnetic resonance to evaluate tissue oxygenation in renal artery stenosis. , 2008, Journal of the American Society of Nephrology : JASN.

[12]  H. Krum,et al.  Renal sympathetic-nerve ablation for uncontrolled hypertension. , 2009, The New England journal of medicine.

[13]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[14]  W. Elliott Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline , 2009 .

[15]  H. Krum,et al.  Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial , 2010, The Lancet.

[16]  W. J. Elliott,et al.  Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study , 2010 .

[17]  L. Lerman,et al.  Preserved Oxygenation Despite Reduced Blood Flow in Poststenotic Kidneys in Human Atherosclerotic Renal Artery Stenosis , 2010, Hypertension.

[18]  Symplicity Htn Investigators,et al.  Catheter-Based Renal Sympathetic Denervation for Resistant Hypertension: Durability of Blood Pressure Reduction Out to 24 Months , 2011, Hypertension.

[19]  Dominik Linz,et al.  Renal Hemodynamics and Renal Function After Catheter-Based Renal Sympathetic Denervation in Patients With Resistant Hypertension , 2012, Hypertension.

[20]  L. Lerman,et al.  Compartmental Analysis of Renal BOLD MRI Data: Introduction and Validation , 2011, Investigative radiology.

[21]  C. Tsioufis,et al.  Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial , 2013, European heart journal.

[22]  Jeroen J. Bax,et al.  2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, Blood pressure.

[23]  E. Vink,et al.  Eligibility for percutaneous renal denervation: the importance of a systematic screening , 2013, Journal of hypertension.

[24]  H. Krum,et al.  Ambulatory Blood Pressure Changes After Renal Sympathetic Denervation in Patients With Resistant Hypertension , 2013, Circulation.

[25]  J. Ormiston,et al.  First-in-human use of the OneShot™ renal denervation system from Covidien. , 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[26]  M. Uder,et al.  Vascular and renal hemodynamic changes after renal denervation. , 2013, Clinical journal of the American Society of Nephrology : CJASN.

[27]  T. Leiner,et al.  Inhibition of the Renin‐Angiotensin System Affects Kidney Tissue Oxygenation Evaluated by Magnetic Resonance Imaging in Patients With Chronic Kidney Disease , 2014, Journal of clinical hypertension.